Understanding how certain bacteria fuse their membranes to resist antibiotics
Mechanism of membrane fusion involving the Gram-negative bacteria outer membrane
This study is looking at how certain tough bacteria connect with our cells and how we can use special proteins to help deliver antibiotics right where they're needed, which could lead to better treatments for infections caused by these resistant bacteria.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | City College of New York NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10824419 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which Gram-negative bacteria, known for their antibiotic resistance, fuse their membranes with those of their hosts. By studying the fusion process initiated by specific proteins from bacteriophages, the research aims to develop nanotherapeutics that can effectively deliver antibiotics across the bacteria's protective outer membrane. The approach involves advanced imaging techniques like cryo-electron microscopy to visualize the interactions at a molecular level. This could lead to innovative strategies for overcoming bacterial resistance and improving treatment options.
Who could benefit from this research
Good fit: Patients suffering from infections caused by Gram-negative bacteria, particularly those resistant to current antibiotic treatments, would be ideal candidates for potential benefits from this research.
Not a fit: Patients with infections caused by Gram-positive bacteria or those not affected by antibiotic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively combat antibiotic-resistant bacterial infections.
How similar studies have performed: Other research has shown promise in developing nanotherapeutics for antibiotic delivery, but this specific approach focusing on Gram-negative bacteria is relatively novel.
Where this research is happening
New York, United States
- City College of New York — New York, United States (Active)
Researchers
- Principal investigator: Khayat, Reza — City College of New York
- Study coordinator: Khayat, Reza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.